The Meaning Behind Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Baudax Bio BXRX - P/E: 0.71
- Cigna CI - P/E: 9.17
- 9 Meters Biopharma NMTR - P/E: 6.47
- Sage Therapeutics SAGE - P/E: 3.22
- Relay Therapeutics RLAY - P/E: 7.73
Baudax Bio's earnings per share for Q2 sits at -0.21, whereas in Q1, they were at -0.27. Baudax Bio does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Cigna has reported Q2 earnings per share at 5.24, which has increased by 10.78% compared to Q1, which was 4.73. Its most recent dividend yield is at 1.75%, which has increased by 0.15% from 1.6% in the previous quarter.
9 Meters Biopharma looks to be undervalued. It possesses an EPS of -0.03, which has not changed since last quarter (Q1). 9 Meters Biopharma does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Sage Therapeutics has reported Q2 earnings per share at -1.83, which has decreased by 11.59% compared to Q1, which was -1.64. Sage Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Relay Therapeutics has reported Q2 earnings per share at -0.64, which has decreased by 36.17% compared to Q1, which was -0.47. Relay Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.